We have touched on the topic of Templeton's now extensive funding of philosophy-related projects before, but over the weekend, Jason Stanley (Rutgers, moving to Yale) started a lively discussion on Facebook with this comment, which he gave me permission to repost here:
Because of Templeton, we may expect a huge number of papers and books in our field taking a religious perspective at the very least extremely seriously. This is not why I entered philosophy, and it is incompatible with my conception of its role in the university. I will not take any money from Templeton or speak at any Templeton funded conferences. Reasonable people may disagree, but I hope there are others who join me in so doing.
In the discussion that followed, the neuroscientist John Krakauer (Johns Hopkins) made a striking comment in support of Jason's suggestion, which he also kindly gave permission to repost here:
Thoughts from readers? Please do check out the earlier links and discussions. Comments must include a full name and a valid e-mail address, or they will not appear.In the Wikipedia entry on Templeton, Dennett describes the experience of debating astrologers at an event and finding to his dismay that just doing this raised the respectability of astrology in the eyes of the audience. Templeton is not about the study of religion but about making sure that religion keeps a seat at the table when it comes to big questions. There is no better way to do this than to mix it up with scientists and philosophers. Can you imagine the reverse ever being necessary?
Drug companies love to be associated with whom they call "thought leaders" - these physicians are never explicitly asked to shill for the companies but they also rarely criticize the companies from that position. It is always good to institutionalize ( or pay) your rebels. Physicians who receive any kind of gift from drug companies from lunches to pens and free samples always say (there are studies on this) that they are not influenced and feel no pressure. The studies reveal otherwise.